venBio Select Advisor as of Dec. 31, 2018
Portfolio Holdings for venBio Select Advisor
venBio Select Advisor holds 35 positions in its portfolio as reported in the December 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Immunomedics | 15.1 | $253M | 18M | 14.27 | |
| Mirati Therapeutics | 12.2 | $204M | 4.8M | 42.42 | |
| Sarepta Therapeutics (SRPT) | 8.3 | $139M | 1.3M | 109.13 | |
| Ascendis Pharma A S (ASND) | 7.4 | $124M | 2.0M | 62.65 | |
| BioMarin Pharmaceutical (BMRN) | 6.9 | $116M | 1.4M | 85.15 | |
| Amicus Therapeutics (FOLD) | 5.8 | $97M | 10M | 9.58 | |
| Iovance Biotherapeutics (IOVA) | 5.4 | $91M | 10M | 8.85 | |
| Horizon Pharma | 5.1 | $85M | 4.4M | 19.54 | |
| Argenx Se (ARGX) | 4.9 | $83M | 860k | 96.07 | |
| Amarin Corporation (AMRN) | 4.5 | $76M | 5.6M | 13.61 | |
| Zogenix | 4.3 | $72M | 2.0M | 36.46 | |
| Loxo Oncology | 2.7 | $46M | 325k | 140.07 | |
| Tricida | 2.5 | $41M | 1.8M | 23.58 | |
| Allogene Therapeutics (ALLO) | 1.7 | $28M | 1.1M | 24.59 | |
| Madrigal Pharmaceuticals (MDGL) | 1.5 | $25M | 225k | 112.72 | |
| Assembly Biosciences | 1.4 | $23M | 1.0M | 22.62 | |
| Tg Therapeutics (TGTX) | 1.2 | $20M | 4.8M | 4.10 | |
| Intec Pharma | 1.1 | $19M | 2.5M | 7.54 | |
| BioDelivery Sciences International | 1.1 | $18M | 4.7M | 3.70 | |
| Pacira Pharmaceuticals (PCRX) | 1.0 | $17M | 400k | 43.02 | |
| Xenon Pharmaceuticals (XENE) | 0.9 | $15M | 2.4M | 6.31 | |
| Global Blood Therapeutics In | 0.9 | $14M | 350k | 41.05 | |
| Ptc Therapeutics I (PTCT) | 0.8 | $13M | 380k | 34.32 | |
| Establishment Labs Holdings Ord (ESTA) | 0.8 | $13M | 475k | 27.42 | |
| Teligent | 0.4 | $7.3M | 5.3M | 1.37 | |
| Fennec Pharmaceuticals (FENC) | 0.4 | $7.1M | 1.1M | 6.38 | |
| Y Mabs Therapeutics (YMAB) | 0.4 | $6.3M | 310k | 20.34 | |
| Kodiak Sciences (KOD) | 0.4 | $6.4M | 902k | 7.10 | |
| Alimera Sciences | 0.3 | $4.5M | 6.2M | 0.72 | |
| Proteostasis Therapeutics In | 0.2 | $4.2M | 1.3M | 3.24 | |
| Acer Therapeutics | 0.2 | $3.0M | 150k | 20.12 | |
| Pernix Therapeutics Hldgs In dbcv 4.250% 4/0 | 0.1 | $2.5M | 6.0M | 0.42 | |
| SPDR S&P Biotech (XBI) | 0.1 | $1.4M | 500k | 2.88 | |
| Outlook Therapeutics | 0.0 | $340k | 680k | 0.50 | |
| Neurocrine Biosciences (NBIX) | 0.0 | $15k | 50k | 0.30 |
